[Curative effects and influenced factors of primary chemotherapy with single-agent methotrexate on low-risk gestational trophoblastic neoplasia].

Wu, X D; Chen, L L; Shen, T; Chen, S S; Chen, Q Q; Qin, J L; Fu, Y F; Lü, W G

Wu, X D; Chen, L L; Shen, T; Chen, S S; Chen, Q Q; Qin, J L; Fu, Y F; Lü, W G.

Affiliation

Wu XD; Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, China.

Zhonghua Yi Xue Za Zhi ; 97(23): 1769-1772, 2017 Jun 20.

Article in Zh | MEDLINE | ID: mdl-28647996

Subject(s)

Gestational Trophoblastic Disease/drug therapy; Methotrexate/therapeutic use; Antimetabolites, Antineoplastic; Female; Humans; Pregnancy; Retrospective Studies; Risk Factors; Salvage Therapy

Key words

Chemotherapy; Gestational trophoblastic neoplasia; Methotrexate

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Gestational Trophoblastic Disease Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Pregnancy Language: Zh Journal: Zhonghua Yi Xue Za Zhi Year: 2017 Document type: Article

Fulltext

XML

PubMed Links

Search on Google